Literature DB >> 17186263

Neurofibromatosis 2 leads to choroidal hyperfluorescence in fluorescein angiography.

Matthias Feucht1, Gisbert Richard, Victor-Felix Mautner.   

Abstract

BACKGROUND: For the diagnosis of NF 2, ocular findings like juvenile cataract, retinal and combined hamartomas of the retinal pigment epithelium and the retina as well as tumours of the optic nerve play an important role. An early diagnosis is essential in order to inhibit deafness from bilateral vestibular schwannoma. But sometimes the Manchester diagnostic criteria for NF2 are not completely fulfilled. Frequently, suspicious macular anatomy is found in neurofibromatosis 2 (NF2) patients. We hypothesise that the underlying retinal pigment epithelium or the retina of the macular region alters in NF2 patients. Therefore, we have tested by fluorescence angiography whether NF2 is associated with chorioretinal changes. METHODS AND PATIENTS: In a prospective study, 48 patients matching the criteria for NF2 with known genotype underwent a complete ophthalmic examination including funduscopy and fluorescence angiography. The influence of the genotype was statistically analysed by odds ratios and their 95% confidence intervals.
RESULTS: Eleven eyes of nine patients showed choroidal hyperfluorescence in the macular region on fluorescence angiography. There was staining spreading from grainy hyperfluorescence to minor variants of a combined hamartoma of the retina and the retinal pigment epithelium. All of these manifestations presented without leakage in the late angiographic phases. These choroidal findings were present in one patient with frameshift mutation, in two patients with nonsense mutations and in six patients with splice site mutations of the NF2 gene. The statistical analysis showed a significant lower risk of choroidal alterations in patients with somatic mosaicism, deletions and unfound mutations.
CONCLUSION: Using fluorescence angiography pathological changes of the macular region can be detected in NF2 patients. The ophthalmic examination, which often is limited to the anterior eye segment, may play a role in finding the diagnosis in incomplete NIH criteria. The presented study shows chorioretinal hyperfluorecences without leakage of the macular region, which might be considered as a forme fruste of a hamartoma. Choroidal hyperfluorescences add to the spectrum of genotype-phenotype correlations in NF2.

Entities:  

Mesh:

Year:  2006        PMID: 17186263     DOI: 10.1007/s00417-006-0454-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  21 in total

1.  Eye findings in bilateral acoustic (central) neurofibromatosis: association with presenile lens opacities and cataracts but absence of Lisch nodules.

Authors:  M A Pearson-Webb; M I Kaiser-Kupfer; R Eldridge
Journal:  N Engl J Med       Date:  1986-12-11       Impact factor: 91.245

2.  Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study.

Authors:  Barbara E K Klein; Ronald Klein; Kristine E Lee
Journal:  Ophthalmology       Date:  2002-11       Impact factor: 12.079

3.  Retinal hamartoma in neurofibromatosis 2.

Authors:  K Landau; F M Dossetor; W F Hoyt; R Muci-Mendoza
Journal:  Arch Ophthalmol       Date:  1990-03

4.  Genotype-phenotype correlations for cataracts in neurofibromatosis 2.

Authors:  M E Baser; L Kuramoto; H Joe; J M Friedman; A J Wallace; R T Ramsden; D G R Evans
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

5.  Bilateral retinal hamartomas in neurofibromatosis type 2.

Authors:  W V Good; M C Erodsky; M S Edwards; W F Hoyt
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

6.  Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study.

Authors:  Samantha Fraser-Bell; Magdalena Guzowski; Elena Rochtchina; Jie Jin Wang; Paul Mitchell
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

7.  A clinical study of type 2 neurofibromatosis.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; V Newton; R Harris
Journal:  Q J Med       Date:  1992-08

8.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.

Authors:  G A Rouleau; P Merel; M Lutchman; M Sanson; J Zucman; C Marineau; K Hoang-Xuan; S Demczuk; C Desmaze; B Plougastel
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

9.  Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.

Authors:  D M Parry; R Eldridge; M I Kaiser-Kupfer; E A Bouzas; A Pikus; N Patronas
Journal:  Am J Med Genet       Date:  1994-10-01

10.  Ocular abnormalities in neurofibromatosis 2.

Authors:  N K Ragge; M E Baser; J Klein; A Nechiporuk; J Sainz; S M Pulst; V M Riccardi
Journal:  Am J Ophthalmol       Date:  1995-11       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.